Safilo Group S.p.A.
General ticker "SAFLF" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $984.5M (TTM average)
Safilo Group S.p.A. follows the US Stock Market performance with the rate: 29.8%.
Estimated limits based on current volatility of 0.0%: low 2.58$, high 2.58$
Short-term SAFLF quotes
Long-term SAFLF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,024.73MM | €993.22MM | €983.01MM |
| Operating Expenses | €1,017.07MM | €953.83MM | €918.85MM |
| Operating Income | €7.66MM | €39.39MM | €64.16MM |
| Non-Operating Income | €-27.12MM | €-7.67MM | €2.77MM |
| Interest Expense | €20.59MM | €10.20MM | €7.14MM |
| R&D Expense | €14.00MM | €0.00MM | €0.00MM |
| Income(Loss) | €-19.46MM | €31.72MM | €66.93MM |
| Taxes | €6.63MM | €9.90MM | €18.74MM |
| Net Income(Loss)* | €-24.65MM | €22.30MM | €49.05MM |
| Stockholders Equity | €379.20MM | €413.07MM | €392.31MM |
| Inventory | €228.99MM | €210.17MM | €171.19MM |
| Assets | €855.46MM | €842.34MM | €758.67MM |
| Operating Cash Flow | €47.71MM | €76.22MM | €89.65MM |
| Capital expenditure | €13.21MM | €48.71MM | €8.40MM |
| Investing Cash Flow | €-8.65MM | €-48.87MM | €-23.55MM |
| Financing Cash Flow | €-40.47MM | €-54.83MM | €-58.56MM |
| Earnings Per Share** | €-0.06 | €0.05 | €0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.